← Back to all articles
ReviewsPubMed Verified

Psychedelic therapy: a primer for primary care clinicians - N,N-dimethyltryptamine and ayahuasca

Shinozuka K, Tabaac BJ, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS

American Journal of Therapeutics (2024)

Clinical primer / review
Abstract

Clinical primer for primary care physicians on DMT and ayahuasca as emerging therapeutic agents. Covers pharmacology, clinical evidence, safety considerations, and practical guidance for clinicians encountering patients who use or inquire about ayahuasca-based therapies.

Citations10
Study TypeClinical primer / review
primary careclinical primerDMTayahuascaphysician guide
DOI: 10.1097/MJT.0000000000001725View on PubMed

Related Articles

Reviews

Ayahuasca and pain: a systematic review of preclinical studies

Goncalves J, Luis A et al.

Psychoactives, 2025
Reviews

Clinical pharmacology of ayahuasca: potential applications and future considerations

Guerra LTL, da Silva Dias IC et al.

Expert Review of Clinical Pharmacology, 2025
Reviews

Ayahuasca: pharmacology, safety, and therapeutic effects

Dos Santos RG, Hallak JEC

CNS Spectrums, 2024
Reviews

The effects of ayahuasca on psychological disorders: a systematic literature review

Sheth R, Parikh E et al.

Cureus, 2024